KINAXO ENTERS INTO AGREEMENT WITH SCHERING AG ON KINASE INHIBITOR PROFILING

KINAXO Biotechnologies GmbH announced that it has entered into a services and collaboration agreement with Schering AG, Germany. Under the agreement, KINAXO will employ the KinaTor technology to perform selectivity analyses for Schering AG's small molecule kinase inhibitors. The results of this study will support Schering AG's lead optimization activities in the field of kinase inhibitors.

Hugin (http://www.huginonline.com/plsql/try/pressreleases.queryview?P_IDENTIFIER=1065800&Z_CHK=32060&p_la=5&p_web=5)